Merck & Co., Inc. (MRK)
108.10
-1.09
(-1.00%)
USD |
NYSE |
Jan 13, 10:33
Merck Free Cash Flow: 13.05B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Cidara Therapeutics, Inc. | -132.94M |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 7.822B |
| Cash from Investing (Quarterly) | -283.00M |
| Cash from Financing (Quarterly) | 2.638B |
| Free Cash Flow Per Share (Quarterly) | 2.736 |
| Free Cash Flow to Equity (Quarterly) | 863.00M |
| Free Cash Flow to Firm (Quarterly) | 7.116B |
| Free Cash Flow Yield | 4.79% |